The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Open accessAbstract
BACKGROUND: The objective of this comparative neuropathologic study was to determine the extent to which dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) are distinct entities or part of a continuum with respect to the duration of parkinsonism. METHODS: We evaluated the relationship between cortical alpha-synuclein pathology, plaques (Consortium to Establish a Registry for Alzheimer's Disease [CERAD]), tangles (Braak staging), and cholinergic deficits (choline acetyltransferase in temporal cortex) in 57 prospectively assessed patients (29 DLB, 28 PDD), confirmed at autopsy. The PDD group was divided according to the median duration of parkinsonism prior to dementia. RESULTS: There was an association between longer duration of parkinsonism prior to dementia and less severe cortical alpha-synuclein pathology (chi(2) 10.4, df 2, p = 0.006) and lower CERAD plaque scores (chi(2) 26.6, df 9, p = 0.002), but not Braak staging. These findings were confirmed in a further correlation analysis, which also identified an unexpected correlation between more pronounced cortical cholinergic deficits and longer duration of parkinsonism prior to dementia (R = -0.37, p = 0.04). CONCLUSION: While there is a clear relationship between the duration of Parkinson disease prior to the onset of dementia and key neuropathologic and neurochemical characteristics, there is a gradation of these differences across the dementia with Lewy bodies/Parkinson disease dementia spectrum and the findings do not support an arbitrary cut-off between the two disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationDiagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding, A., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609
Senile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., FAIRBAIRN, A. F., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 575
Self-citationParkinson Disease Neuropathology
Apaydın, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.102 · Cited by 397
Research works printed but not linked: 3
- Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229–237.
- Perry RH Jaros E Hall RA et al. Proposal for modification of consensus guidelines for the neuropathological diagnosis of dementia with Lewy bodies (DLB) when using alfa-synuclein IHC. Third International Workshop on Dementia with Lewy Bodies and Parkinson's Disease. Dementia. Vol. 158. Newcastle upon Tyne UK 2003;158.
- Lippa SM, Lippa CF, Mori H. Alpha-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am J Alzheimers Dis Other Dement 2005;20:315–318.
Cited by
Sorted by citations
Items 101–200 of 335
Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases
Lee, S. H., Cho, H., Choi, J. Y., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Movement Disorders · doi:10.1002/mds.27252 · Cited by 71
Prodromal dementia with L ewy bodies
Fujishiro, H., Nakamura, S., Sato, K., & Iseki, E. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12466 · Cited by 68
Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
Mueller, C., Rajkumar, A. P., Wan, Y.-M., Velayudhan, L., Ffytche, D. H., Chaudhuri, К. R., & Aarsland, D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0540-6 · Cited by 78
Self-citationFujishiro, H., Iseki, E., Higashi, S., Kasanuki, K., Murayama, N., Togo, T., Katsuse, O., Uchikado, H., Aoki, N., Kosaka, K., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.036 · Cited by 70
β‐amyloid in lewy body disease is related to Alzheimer's disease‐like atrophy
Shimada, H., Shinotoh, H., Hirano, S., Miyoshi, M., Sato, K., Tanaka, N., Ota, T., Fukushi, K., Irie, T., Ito, H., et al. (2012) · Movement Disorders · doi:10.1002/mds.25286 · Cited by 64
Cerebrospinal fluid amyloid- and phenotypic heterogeneity in de novo Parkinson's disease
Alves, G. W., Pedersen, K. F., Bloem, B. R., Blennow, K., Zetterberg, H., Borm, G. F., Dalaker, T. O., Beyer, M. K., Aarsland, D., Andréasson, U., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303808 · Cited by 66
Self-citationGratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Brechany, U., McNichol, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., et al. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.04.010 · Cited by 64
Self-citationLiu, A. K. L., Chau, T. W., Lim, E., Ahmed, I., Chang, R. C., Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0717-3 · Cited by 64
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Friedman, J. H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.013 · Cited by 63
Biomarkers in Parkinson’s disease: A state of the art review
Yamashita, K. Y., Bhoopatiraju, S., Silverglate, B., & Grossberg, G. T. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100074 · Cited by 62
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0466-z · Cited by 60
Chin, K. S., Yassi, N., Churilov, L. P., Masters, C. L., & Watson, R. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.030 · Cited by 60
Compta, Y., & Révész, T. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202323 · Cited by 61
Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
Borghammer, P., Okkels, N., & Weintraub, D. A. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240002 · Cited by 57
Vranová, H. P., Hényková, E., Kaiserová, M., Menšíková, K., Vaštík, M., Mareš, J., Hluštı́k, P., Zapletalová, J., Strnad, M., Stejskal, D., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.052 · Cited by 57
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 59
Lebedev, A. V., Westman, E., Beyer, M. K., Kramberger, M. G., Aguilar, C., Pirtošek, Z., & Aarsland, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6768-z · Cited by 55
Self-citationBousiges, O., Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin‐Hunyadi, C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150731 · Cited by 59
Sharp, S. I., Ballard, C. G., Ziabreva, I., Piggott, M. A., Perry, R. H., Perry, E. K., Aarsland, D., Ehrt, U., Larsen, J. O., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161058 · Cited by 55
Self-citationUnfolded protein response is activated in L ewy body dementias
Baek, J., Whitfield, D., Howlett, D. C., Francis, P. T., Bereczki, E., Ballard, C. G., Hortobágyi, T., Attems, J., & Aarsland, D. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12260 · Cited by 55
Self-citationAmyloid Pathology Influences Aβ1-42 Cerebrospinal Fluid Levels in Dementia with Lewy Bodies
Slaets, S., Bastard, N. L., Theuns, J., Sleegers, K., Verstraeten, A., Leenheir, E. D., Luyckx, J., Martin, J., Broeckhoven, C. V., & Engelborghs, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122176 · Cited by 54
Tröster, A. I. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711000257 · Cited by 54
Mouton, A., Blanc, F., Gros, A., Manera, V., Fabre, R., Sauleau, E., Gomez-Luporsi, I., Tifratène, K., Friedman, L., Thümmler, S., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0417-4 · Cited by 52
Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
Bousiges, O., & Blanc, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126371 · Cited by 60
Systems biology of neurodegenerative diseases
Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 56
Cognitive Impairment in Parkinson’s Disease and Dementia with Lewy Bodies: A Spectrum of Disease
Gross, R. G., Siderowf, A. D., & Hurtig, H. I. (2007) · Neurosignals · doi:10.1159/000109756 · Cited by 53
Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia
Aarsland, D., Ballard, C. G., Rongve, A., Broadstock, M., & Svenningsson, P. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0290-7 · Cited by 52
Self-citationClinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
Donaghy, P. C., Firbank, M. J., Thomas, A. J., Lloyd, J., Petrides, G., Barnett, N., Olsen, K., & O'Brien, J. T. (2018) · Movement Disorders · doi:10.1002/mds.27403 · Cited by 52
Self-citationCerebral amyloid angiopathy in Lewy body disease
Jellinger, K. A., & Attems, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0856-8 · Cited by 50
Neuropathological correlates of neuropsychiatric symptoms in dementia
Gibson, L. L., Grinberg, L. T., Ffytche, D. H., Leite, R. E. P., Rodriguez, R. D., Ferretti‐Rebustini, R. E. D. L., Pasqualucci, C. A., Nitríni, R., Filho, W. J., Aarsland, D., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12765 · Cited by 51
Self-citationSynucleinopathies: common features and hippocampal manifestations
Yang, W., & Yu, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2411-y · Cited by 49
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Becker, K., Wang, X., Stel, K. J. V., Chu, Y., Kordower, J. H., & Ma, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1007-y · Cited by 49
Treatment of Dementia with Lewy Bodies and Parkinsonʼs Disease Dementia
Ballard, C. G., Kahn, Z., & Corbett, A. (2011) · Drugs & Aging · doi:10.2165/11594110-000000000-00000 · Cited by 48
Self-citationRole of Neuroimaging as a Biomarker for Neurodegenerative Diseases
Shimizu, S., Hirose, D., Hatanaka, H., Takenoshita, N., Kaneko, Y., Ogawa, Y., Sakurai, H., & Hanyu, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00265 · Cited by 52
Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies
Gomperts, S. N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0472-6 · Cited by 47
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
Fan, T.-S., Liu, S. C.-H., & Wu, R. (2021) · Life · doi:10.3390/life11111239 · Cited by 47
Walker, L., & Attems, J. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230154 · Cited by 48
Plasticity in Early Alzheimer Disease
Hill, N. L., Kolanowski, A. M., & Gill, D. J. (2011) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0b013e31821e588e · Cited by 51
Clinical drug development for dementia with Lewy bodies: past and present
Lee, G., Cummings, J. L., Decourt, B., Leverenz, J. B., & Sabbagh, M. N. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1681398 · Cited by 46
Use of Cholinesterase Inhibitors in Non-Alzheimer’s Dementias
Noufi, P., Khoury, R., Jeyakumar, S., & Grossberg, G. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00685-6 · Cited by 37
Vernon, A. C., Ballard, C. G., & Modo, M. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.006 · Cited by 44
Self-citationQuantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
Miller, R. L., Dhavale, D. D., O’Shea, J. Y., Andruska, K. M., Liu, J., Franklin, E. E., Buddhala, C., Loftin, S. K., Cirrito, J. R., Perrin, R. J., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51482 · Cited by 43
Bousiges, O., Bombois, S., Schraen‐Maschke, S., Wallon, D., Quillard‐Muraine, M., Gabelle, A., Lehmann, S., Paquet, C., Bouaziz-Amar, É., Magnin, É., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316385 · Cited by 42
Ziebell, M., Andersen, B. B., Pinborg, L. H., Knudsen, G. M., Stokholm, J., Thomsen, G. K., Karlsborg, M., Høgh, P., Mørk, M. L., & Hasselbalch, S. G. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114025 · Cited by 41
Weil, R. S., Lashley, T., Brás, J., Schrag, A. E., & Schott, J. M. (2017) · F1000Research · doi:10.12688/f1000research.11725.1 · Cited by 41
Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs
Kanel, P., Müller, M. L. T. M., van der Zee, S., Sánchez-Catasús, C. A., Koeppe, R. A., Frey, K. A., & Bohnen, N. I. (2020) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19070165 · Cited by 40
Santangelo, R., Cecchetti, G., Bernasconi, M. P., Cardamone, R., Barbieri, A., Pinto, P., Passerini, G., Scomazzoni, F., Comı, G., & Magnani, G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170186 · Cited by 42
miRNAs Identify Shared Pathways in Alzheimer’s and Parkinson’s Diseases
Sadlon, A., Takousis, P., Alexopoulos, P., Εvangelou, Ε., Prokopenko, I., & Perneczky, R. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.006 · Cited by 40
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study
Biundo, R., Weis, L., Fiorenzato, E., Pistonesi, F., Cagnin, A., Bertoldo, A., Anglani, M., Cecchin, D., & Antonini, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab180 · Cited by 39
Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
Deleidi, M., & Maetzler, W. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/391438 · Cited by 40
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases
Campbell, M. C., Markham, J., Flores, H. P., Hartlein, J. M., Goate, A., Cairns, N. J., Videen, T. O., & Perlmutter, J. S. (2013) · Neurology · doi:10.1212/wnl.0b013e31829e6f94 · Cited by 39
Review: Clinical, neuropathological and genetic features of Lewy body dementias
Hansen, D., Ling, H., Lashley, T., Holton, J. L., & Warner, T. T. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12554 · Cited by 41
Yang, L., Zhang, X., Li, S., Wang, H., Zhang, X., Liu, L., & Xie, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118159 · Cited by 36
Gatt, A. P., Jones, E. L., Francis, P. T., Ballard, C. G., & Bateman, J. E. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.045 · Cited by 36
Self-citationBiomarkers for Cognitive Impairment in Parkinson Disease
Shi, M. Y., Huber, B. R., & Zhang, J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00370.x · Cited by 35
Akhtar, A., Singh, S., Kaushik, R., Awasthi, R., & Behl, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102289 · Cited by 38
Cerebral Microbleeds in Patients with Dementia with Lewy Bodies and Parkinson Disease Dementia
Kim, S. W., Chung, S. J., Oh, Y., Yoon, J. H., Sunwoo, M. K., Hong, J. Y., Kim, J.-S., & Lee, P. H. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4337 · Cited by 34
“Parkinson-dementia” diseases: A comparison by double tracer SPECT studies
Rossi, C. A., Volterrani, D., Nicoletti, V., Manca, G., Frosini, D., Kiferle, L., Unti, E., Feo, P. D., Bonuccelli, U., & Ceravolo, R. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.012 · Cited by 31
Shahid, M., Kim, J., Leaver, K. R., Hendershott, T. R., Zhu, D., Cholerton, B., Henderson, V. W., Tian, L., & Poston, K. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.023 · Cited by 34
Dopaminergic Depletion, β‐Amyloid Burden, and Cognition in Lewy Body Disease
Yoo, H. S., Lee, S., Chung, S. J., Lee, Y. H., Lee, P. H., Sohn, Y. H., Lee, S., Yun, M., & Ye, B. S. (2020) · Annals of Neurology · doi:10.1002/ana.25707 · Cited by 34
Šmid, L. M., Kepe, V., Vinters, H. V., Bresjanac, M., Toyokuni, T., Satyamurthy, N., Wong, K. P., Huang, S., Silverman, D. H. S., Miller, K. J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122434 · Cited by 33
Jellinger, K. A. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.05.024 · Cited by 34
Lerche, S., Machetanz, G., Wurster, I., Röeben, B., Zimmermann, M., Pilotto, A., Preische, O., Stransky, E., Deuschle, C., Hauser, A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27731 · Cited by 32
Aldrin-Kirk, P., Davidsson, M., Holmqvist, S., Li, J., & Björklund, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100869 · Cited by 32
Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?
Wen, M., Chan, L. L., Tan, L. C. S., & Tan, E. K. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0094-4 · Cited by 33
Bousiges, O., Philippi, N., Lavaux, T., Perret‐Liaudet, A., Lachmann, I., Schaeffer‐Agalède, C., Anthony, P., Botzung, A., Rauch, L., Jung, B., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00684-5 · Cited by 33
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 35
Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review
Morra, L. F., & Donovick, P. J. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4039 · Cited by 31
Chaudhry, A., Houlden, H., & Rizig, M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116886 · Cited by 33
Bellomo, G., Paoletti, F. P., Chipi, E., Petricciuolo, M., Simoni, S., Tambasco, N., & Parnetti, L. (2020) · Diagnostics · doi:10.3390/diagnostics10121015 · Cited by 30
Sierra, M., Gelpí, E., Martı́, M. J., & Compta, Y. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12308 · Cited by 30
Neuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 31
Commentary: DLB and PDD: the same or different? Is there a debate?
McKeith, I. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610208008624 · Cited by 30
Self-citationShin, N. Y., Shin, Y., Lee, P. H., Yoon, U., Han, S., Kim, D. J., & Lee, S. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4626 · Cited by 29
Santangelo, R., Dell’Edera, A., Sala, A., Cecchetti, G., Masserini, F., Caso, F., Pinto, P., Leocani, L., Falautano, M., Passerini, G., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190725150836 · Cited by 27
A sensitive assay reveals structural requirements for α-synuclein fibril growth
Dhavale, D. D., Tsai, C., Bagchi, D. P., Engel, L. A., Sarezky, J., & Kotzbauer, P. T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767053 · Cited by 26
Core and Suggestive Symptoms of Dementia with Lewy Bodies Cluster in Persons with Mild Dementia
Rongve, A., Brønnick, K., Ballard, C. G., & Aarsland, D. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000295111 · Cited by 25
Self-citationHuang, X., Wang, C., Chen, L., Zhang, T., Leung, K. L., & Wong, G. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166203 · Cited by 26
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits
Granert, O., Drzezga, A. E., Boecker, H., Perneczky, R., Kurz, A., Götz, J., van Eimeren, T., & Häussermann, P. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156067 · Cited by 24
Kim, I., Shin, N., Bak, Y., Lee, P. H., Lee, S., & Lim, S. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02420-w · Cited by 23
Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
Lauterbach, E. C., Shillcutt, S. D., Victoroff, J., Coburn, K. L., & Mendez, M. F. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.2.130 · Cited by 22
Imaging in Dementia With Lewy Bodies
Watson, R., & Colloby, S. J. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654984 · Cited by 22
A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review
Khan, M. A., Quadri, S. A., & Tohid, H. (2017) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2017.81.1.53 · Cited by 21
Criteria for the diagnosis of dementia
Ballard, C. G. (2010) · CRC Press eBooks · doi:10.1201/b13196-17 · Cited by 21
Self-citationThe Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s Disease
Engelborghs, S., & Bastard, N. L. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03262201 · Cited by 20
Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases
Jellinger, K. A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02345-9 · Cited by 21
Clinical indications for analysis of Alzheimer's disease CSF biomarkers
Engelborghs, S. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.024 · Cited by 20
Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease
n, M. S.-R., Sáenz‐Farret, M., Miguel‐Puga, J. A., Micheli, F. E., & Arias-Carrión, Ó. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00071 · Cited by 19
The Treatment of Cognitive Impairment Associated with Parkinson's Disease
Burn, D. J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00367.x · Cited by 19
The role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19
Grey matter atrophy in early versus late dementia in Parkinson's disease
Beyer, M. K., & Aarsland, D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.021 · Cited by 19
Self-citationNeuroimaging of Dementia with Lewy Bodies
Taylor, J., & O'Brien, J. T. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.001 · Cited by 19
Self-citationClinical and neuroimaging characteristics of Chinese dementia with Lewy bodies
Liu, S., Wang, X., Wang, Y., Shi, Z., Cai, L., Liu, S., Han, T., Zhou, Y., Wang, X., Gao, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171802 · Cited by 19
Carli, G., Meles, S. K., Reesink, F. E., de Jong, B. M., Pilotto, A., Padovani, A., Galbiati, A., Ferini‐Strambi, L., Leenders, K. L., & Perani, D. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103475 · Cited by 18
Benussi, A., Pilotto, A., Cantoni, V., Ferrari, E., Borroni, B., & Padovani, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215531 · Cited by 17
Shimizu, S., Kanetaka, H., Hirao, K., Fukasawa, R., Namioka, N., Hatanaka, H., Hirose, D., Umahara, T., Sakurai, H., & Hanyu, H. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12794 · Cited by 17
Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies
Bousiges, O., & Blanc, F. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.11.027 · Cited by 18
An update on brain imaging in parkinsonian dementia
Petrou, M., Kotagal, V., & Bohnen, N. I. (2012) · Imaging in Medicine · doi:10.2217/iim.12.10 · Cited by 16
Challenges in the Neuropathological Diagnosis of Dementias
Jellinger, K. A. (2012) · International Journal of Neuropathology · doi:10.7726/ijn.2013.1002 · Cited by 15
Metadata
- Authors
- Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D.
- Affiliations
- King's College London (GB)
- From the Wolfson Centre for Age-Related Diseases (C.B.), Wolfson Building, Guy's Campus, King's College London, UK; Institute of Ageing and Health (I.Z., R.P., J.O., I.M., E.P.), Newcastle General Hospital, Newcastle upon Tyne, UK; and Norwegian Center for Movement Disorders (J.P.L., D.A.), Stavanger University Hospital, Stavanger, Norway.
- Venue
- Neurology
- Published
- 2006-12-12
- Volume
- 67
- Issue
- 11
- Pages
- 1931-1934
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2107172544
- Cited by
- 335
- References
- 28
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 16 · 2019: 23 · 2018: 23 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 21 · 2013: 25 · 2012: 28
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia with Lewy bodies, Parkinson's disease dementia, alpha-synuclein pathology, Braak staging, cholinergic deficit, choline acetyltransferase, differential diagnosis, neuropathology
- MeSH terms
- Aged, Aged, 80 and over, Choline O-Acetyltransferase, Female, Humans, Male, Parkinson Disease, Prospective Studies, Temporal Lobe, Time Factors, Neurofibrillary Tangles, Lewy Body Disease, alpha-Synuclein, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
